Kenneth Krogulski, Director at CUMBERLAND PHARMACEUTICALS INC (CPIX), bought 1,785 shares at $2.91 ($6K) on 2021-07-01, disclosed to the SEC on 2021-08-13.
Scheduled purchase ($6k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.91 | 85 | $247 | 4.2% |
| 2 | $2.94 | 85 | $250 | 4.3% |
| 3 | $3.14 | 85 | $267 | 4.6% |
| 4 | $3.19 | 85 | $271 | 4.7% |
| 5 | $3.18 | 85 | $270 | 4.6% |
| 6 | $3.13 | 85 |
| $266 |
| 4.6% |
| 7 | $3.33 | 85 | $283 | 4.9% |
| 8 | $3.48 | 85 | $296 | 5.1% |
| 9 | $3.33 | 85 | $283 | 4.9% |
| 10 | $3.27 | 85 | $278 | 4.8% |
| 11 | $3.28 | 85 | $279 | 4.8% |
| 12 | $3.23 | 85 | $275 | 4.7% |
| 13 | $3.24 | 85 | $275 | 4.7% |
| 14 | $3.26 | 85 | $277 | 4.8% |
| 15 | $3.36 | 85 | $286 | 4.9% |
| 16 | $3.35 | 85 | $285 | 4.9% |
| 17 | $3.39 | 85 | $288 | 4.9% |
| 18 | $3.39 | 85 | $288 | 4.9% |
| 19 | $3.42 | 85 | $291 | 5.0% |
| 20 | $3.42 | 85 | $291 | 5.0% |
| 21 | $3.31 | 85 | $281 | 4.8% |
| Total | $3.26 avg | 1,785 | $6K | 100% |
| Filing → |
| CPIX | BUY | 2025-07-11 | $5K | — | Filing → |
| CPIX | BUY | 2025-06-06 | $5K | — | Filing → |
| CPIX | BUY | 2025-05-09 | $5K | — | Filing → |